Neurotoxicity testing
Why us
Our NANOSTACKSTM-based in vitro models recapitulate the cell-cell crosstalk and spatial cellular arrangement typical of the in vivo environment. This way, toxicity screening on our models can yield more in-vivo relevant results than the use of traditional models.
Model Specifications
The model is built on 2 layers, using our proprietary technology NANOSTACKS™
- Layer 1: Glial component
- Cell type: U-138 MG
- U-138 MG cells are an astrocytoma cell line used in the model to model a glial, astrocyte-like component.
- Layer 2: Neuronal component
- Cell type: differentiated SH-SY5Y*
- Differentiated SH-SY5Y cells recapituate aspects of human neurons, and are frequently used in neuroscience and toxicology research. * SH-SY5Y are also available in undifferentiated form.
TYPICAL OUTPUTS
Contact us for alternative endpoints.
DATA
Application Note
Application Note: Development of an in vitro model of the human brain using CELLSTAKS™
In this application note a novel in vitro model of the human brain, comprising 1321N1 cells in addition to undifferentiated or differentiated SH-SY5Y cells, was developed using NANOSTACKS™. This study revealed heightened neurotoxicity of the compound methylglyoxal on the brain model including undifferentiated SH-SY5Y, as compared to monocultures of undifferentiated SH-SY5Y. Furthermore, an assessment of the neurotoxicity of the drug clomipramine was conducted by performing a neurite outgrowth assay on the model including differentiated SH-SY5Y, demonstrating the compatibility of NANOSTACKS™ with imaging-based toxicity assays.
DOWNLOADUnique Benefits
Get in Touch
Explore how our models support your research studies
Alternative solutions
Need some help?
If you're interested in discovering how our organ models can benefit your research, we invite you to get in touch with us. Our team is available to provide further insights and address any inquiries you may have.